REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 135 filers reported holding REVOLUTION MEDICINES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $363,345 | +123908.5% | 13,583 | +0.5% | 0.00% | -20.0% |
| Q1 2023 | $293 | +30.2% | 13,514 | +43.2% | 0.01% | +25.0% |
| Q4 2022 | $225 | -99.9% | 9,439 | -59.0% | 0.00% | -66.7% |
| Q2 2022 | $448,000 | -74.1% | 22,998 | -66.0% | 0.01% | -70.0% |
| Q1 2022 | $1,728,000 | -28.2% | 67,721 | -10.7% | 0.04% | -11.1% |
| Q2 2021 | $2,406,000 | – | 75,797 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 5,524,031 | $139,040,000 | 34.79% |
| Ponoi II Management, LLC | 685,011 | $17,242,000 | 31.32% |
| Nextech Invest Ltd. | 2,968,214 | $74,710,000 | 19.68% |
| Ponoi Management, LLC | 685,011 | $17,242,000 | 15.90% |
| Column Group LLC | 3,347,245 | $84,250,000 | 11.46% |
| TRV GP IV, LLC | 1,419,900 | $35,739,000 | 10.28% |
| Cormorant Asset Management, LP | 2,431,852 | $61,210,000 | 3.64% |
| Boxer Capital, LLC | 3,484,264 | $87,699,000 | 3.41% |
| Casdin Capital, LLC | 2,370,000 | $59,653,000 | 1.68% |
| BVF INC/IL | 1,810,549 | $45,572,000 | 1.65% |